共 12 条
- [1] Rothwell D. G., Et al., Utility of ctDNA to support patient selection for early phase clinical trialsthe TARGET study, Nat. Med, 25, pp. 738-743, (2019)
- [2] Fleischhacker M, et alBiochem Biophys Acta, 1775, pp. 181-232, (2007)
- [3] Tanaka F, Et al., Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer, Clin Cancer Res, 15, 22, pp. 6980-6986, (2009)
- [4] Naito T, Et al., Prognostic Impact of Circulating Tumor Cells in Patients with SmallCellLungCancer, J. Thorac Oncol, 7, 3, pp. 512-519, (2012)
- [5] Sparano J., Et al., Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer, JAMA Oncol, 4, 12, (2018)
- [6] Manz A., Fettinger J. C., Verpoorte E., Ludi H., Widmer H., Harrison D., TrAC Trends in Analytical Chemistry, 10, pp. 144-149, (1991)
- [7] Oki A., Ogawa H., Nagai M., Shinbashi S., Takai M., Yokogawa A., Horiike Y., Materials Science and Engineering, C 24, pp. 837-843, (2004)
- [8] Martinez A. W., Phillips S. T., Whitesides G. M., Proceedings of the National Academy of Sciences, 105, pp. 19606-19611, (2008)
- [9] Huh D., Hamilton G. A., Ingber D. E., Trends in cell biology, 21, pp. 745-754, (2011)
- [10] Zhong J. F., Chen Y., Marcus J. S., Scherer A., Quake S. R., Taylor C. R., WeinerLab L. P., Chip, 8, pp. 68-74, (2007)